Literature DB >> 27514393

Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.

Chang Seong Kim1, Eun Hui Bae1, Seong Kwon Ma1, Sue K Park2,3,4, Ju Yeon Lee2, Wookyung Chung5, Kyubeck Lee6, Yeong Hoon Kim7, Kook-Hwan Oh8, Curie Ahn8, Soo Wan Kim9.   

Abstract

BACKGROUND: High serum adiponectin levels predict all-cause and cardiovascular mortality in chronic kidney disease (CKD). However, the relationship between serum adiponectin concentration and arterial stiffness in CKD is not well established. The aim of this study was to assess this relationship by measuring pulse wave velocity (PWV) in CKD patients.
METHODS: Serum adiponectin concentration was measured in 716 CKD patients in the prospective KoreaN cohort study for Outcome in patients With Chronic Kidney Disease. The study group consisted of 415 men and 301 women; mean age was 53.1 years, and baseline estimated glomerular filtration rate (eGFR) was 51 ± 29 ml/min per 1.73 m2. Heart to femoral PWV (hfPWV) and mean brachial to ankle PWV (baPWV) served as indicators of aortic artery stiffness and arterial stiffness, respectively.
RESULTS: Increasing quartiles of serum adiponectin levels were associated with women, lower eGFRs and body mass indices, and higher urinary albumin-creatinine ratios. Serum adiponectin concentration also correlated with hfPWV and mean baPWV, even after adjusting for age and sex. It independently associated with hfPWV (B 0.028; 95 % confidence interval, 0.004-0.051; P = 0.020) but not mean baPWV in a multivariable linear regression analysis. In a multivariable logistic regression analysis, it correlated significantly with the highest quartile of hfPWVs but not mean baPWVs.
CONCLUSION: The independent and significant correlation of serum adiponectin concentration with hfPWV in CKD patients implicates adiponectin in CKD-associated aortic stiffness.

Entities:  

Keywords:  Adiponectin; Arterial stiffness; Chronic kidney disease; Pulse wave velocity

Mesh:

Substances:

Year:  2016        PMID: 27514393     DOI: 10.1007/s10157-016-1322-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  36 in total

Review 1.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

Review 2.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 3.  Adiponectin as a routine clinical biomarker.

Authors:  Ken Kishida; Tohru Funahashi; Iichiro Shimomura
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-08-20       Impact factor: 4.690

4.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

5.  Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients.

Authors:  Ina Maria Kacso; Cosmina Ioana Bondor; Gabriel Kacso
Journal:  Scand J Clin Lab Invest       Date:  2012-04-10       Impact factor: 1.713

6.  Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model.

Authors:  Keith Ng; Cara M Hildreth; Jacqueline K Phillips; Alberto P Avolio
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-06

7.  Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.

Authors:  Bruno Pannier; Alain P Guérin; Sylvain J Marchais; Michel E Safar; Gérard M London
Journal:  Hypertension       Date:  2005-03-07       Impact factor: 10.190

Review 8.  Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk.

Authors:  D Giannessi; M Maltinti; S Del Ry
Journal:  Pharmacol Res       Date:  2007-09-22       Impact factor: 7.658

Review 9.  Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin.

Authors:  S-H Park; J J Carrero; B Lindholm; P Stenvinkel
Journal:  Clin Nephrol       Date:  2009-08       Impact factor: 0.975

10.  Association of serum adiponectin level with albuminuria in chronic kidney disease patients.

Authors:  Ha Yeon Kim; Eun Hui Bae; Seong Kwon Ma; Dong Wan Chae; Kyu Hun Choi; Yong-Soo Kim; Young-Hwan Hwang; Curie Ahn; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2015-10-07       Impact factor: 2.801

View more
  4 in total

Review 1.  Arterial Stiffness in Hypertension: an Update.

Authors:  Korshie Dumor; Michael Shoemaker-Moyle; Ravi Nistala; Adam Whaley-Connell
Journal:  Curr Hypertens Rep       Date:  2018-07-04       Impact factor: 5.369

Review 2.  The KNOW-CKD Study: What we have learned about chronic kidney diseases.

Authors:  Kook-Hwan Oh; Minjung Kang; Eunjeong Kang; Hyunjin Ryu; Seung Hyeok Han; Tae-Hyun Yoo; Soo Wan Kim; Dong-Wan Chae; Kyu-Beck Lee; Sue K Park; Yeong Hoon Kim; Curie Ahn
Journal:  Kidney Res Clin Pract       Date:  2020-06-30

Review 3.  Adiponectin in Chronic Kidney Disease.

Authors:  Jarosław Przybyciński; Violetta Dziedziejko; Kamila Puchałowicz; Leszek Domański; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

Review 4.  Adipokines and Arterial Stiffness in Obesity.

Authors:  Ioana Para; Adriana Albu; Mihai D Porojan
Journal:  Medicina (Kaunas)       Date:  2021-06-25       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.